Pro Medicus Limited (ASX:PME – Get Free Report) insider Anthony Hall acquired 8,500 shares of the firm’s stock in a transaction on Tuesday, February 24th. The stock was purchased at an average price of A$110.13 per share, with a total value of A$936,105.00.
Anthony Hall also recently made the following trade(s):
- On Tuesday, December 23rd, Anthony Hall bought 2,270 shares of Pro Medicus stock. The shares were acquired at an average cost of A$220.31 per share, with a total value of A$500,103.70.
- On Monday, December 22nd, Anthony Hall acquired 2,250 shares of Pro Medicus stock. The shares were bought at an average cost of A$221.90 per share, for a total transaction of A$499,275.00.
Pro Medicus Price Performance
The company has a debt-to-equity ratio of 1.10, a quick ratio of 4.39 and a current ratio of 5.98. The company has a market cap of $29.16 billion, a price-to-earnings ratio of 351.99, a PEG ratio of 3.87 and a beta of 0.56.
Pro Medicus Dividend Announcement
About Pro Medicus
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.
Recommended Stories
- Five stocks we like better than Pro Medicus
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
